These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


350 related items for PubMed ID: 25468307

  • 1. Mycophenolate mofetil in systemic lupus erythematosus: results from a retrospective study in a large monocentric cohort and review of the literature.
    Conti F, Ceccarelli F, Perricone C, Massaro L, Cipriano E, Pacucci VA, Truglia S, Miranda F, Morello F, Alessandri C, Spinelli FR, Valesini G.
    Immunol Res; 2014 Dec; 60(2-3):270-6. PubMed ID: 25468307
    [Abstract] [Full Text] [Related]

  • 2. Comparison of disease activity between tacrolimus and mycophenolate mofetil in lupus nephritis: a randomized controlled trial.
    Kamanamool N, Ingsathit A, Rattanasiri S, Ngamjanyaporn P, Kasitanont N, Chawanasuntorapoj R, Pichaiwong W, Anutrakulchai S, Sangthawan P, Ophascharoensuk V, Avihingsanon Y, Sumethkul V.
    Lupus; 2018 Apr; 27(4):647-656. PubMed ID: 29105558
    [Abstract] [Full Text] [Related]

  • 3. Mycophenolate mofetil in the treatment of SLE and systemic vasculitis: experience at a single university center.
    Lourdudoss C, Vollenhoven Rv.
    Lupus; 2014 Mar; 23(3):299-304. PubMed ID: 24399811
    [Abstract] [Full Text] [Related]

  • 4. Does mycophenolate mofetil prevent extra-renal flares in systemic lupus erythematosus? Results from an observational study of patients in a single practice treated for up to 5 years.
    Posalski JD, Ishimori Ml, Wallace DJ, Weisman MH.
    Lupus; 2009 May; 18(6):516-21. PubMed ID: 19395453
    [Abstract] [Full Text] [Related]

  • 5. Experience with mycophenolate mofetil as maintenance therapy in five pediatric patients with severe systemic lupus erythematosus.
    Dittrich K, Ross S, Benz K, Amann K, Dötsch J.
    Klin Padiatr; 2009 Dec; 221(7):425-9. PubMed ID: 20013565
    [Abstract] [Full Text] [Related]

  • 6. Tolerability of mycophenolate mofetil in patients with systemic lupus erythematosus.
    Riskalla MM, Somers EC, Fatica RA, McCune WJ.
    J Rheumatol; 2003 Jul; 30(7):1508-12. PubMed ID: 12858449
    [Abstract] [Full Text] [Related]

  • 7. Mycophenolate Mofetil in Nonrenal Manifestations of Systemic Lupus Erythematosus: An Observational Cohort Study.
    Tselios K, Gladman DD, Su J, Urowitz MB.
    J Rheumatol; 2016 Mar; 43(3):552-8. PubMed ID: 26773121
    [Abstract] [Full Text] [Related]

  • 8. Mycophenolate mofetil is effective in reducing disease flares in systemic lupus erythematosus patients: a retrospective study.
    Nannini C, Crowson CS, Matteson EL, Moder KG.
    Lupus; 2009 Apr; 18(5):394-9. PubMed ID: 19318390
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Efficacy of mycophenolate mofetil in Japanese patients with systemic lupus erythematosus.
    Kawazoe M, Kaneko K, Yamada Z, Masuoka S, Mizutani S, Yamada S, Shikano K, Sato H, Kaburaki M, Muraoka S, Kawai S, Nanki T.
    Clin Rheumatol; 2019 Jun; 38(6):1571-1578. PubMed ID: 30778862
    [Abstract] [Full Text] [Related]

  • 13. Mycophenolate mofetil in systemic lupus erythematosus: efficacy and tolerability in 86 patients.
    Pisoni CN, Sanchez FJ, Karim Y, Cuadrado MJ, D'Cruz DP, Abbs IC, Khamasta MA, Hughes GR.
    J Rheumatol; 2005 Jun; 32(6):1047-52. PubMed ID: 15940766
    [Abstract] [Full Text] [Related]

  • 14. Open label randomized controlled trial assessing the efficacy of mycophenolate sodium against other conventional immunosuppressive agents in active systemic lupus erythematosus patients without renal involvement.
    Yahya F, Jasmin R, Ng CT, Cheah TE, Sockalingam S.
    Int J Rheum Dis; 2013 Dec; 16(6):724-30. PubMed ID: 24119227
    [Abstract] [Full Text] [Related]

  • 15. Mycophenolate mofetil and systemic lupus erythematosus: an overview.
    Pisoni CN, Karim Y, Cuadrado MJ.
    Lupus; 2005 Dec; 14 Suppl 1():s9-11. PubMed ID: 15803925
    [Abstract] [Full Text] [Related]

  • 16. Mycophenolate mofetil in the treatment of systemic lupus erythematosus.
    Dall'Era M.
    Curr Opin Rheumatol; 2011 Sep; 23(5):454-8. PubMed ID: 21720247
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Mycophenolate Mofetil and New-Onset Systemic Lupus Erythematosus: A Randomized Clinical Trial.
    You Y, Zhou Z, Wang F, Li J, Liu H, Cheng X, Su Y, Chen X, Zheng H, Sun Y, Shi H, Hu Q, Xu J, Teng J, Yang C, Ye J.
    JAMA Netw Open; 2024 Sep 03; 7(9):e2432131. PubMed ID: 39283640
    [Abstract] [Full Text] [Related]

  • 19. Hypersensitivity to mycophenolate mofetil in systemic lupus erythematosus: diagnostic measures and successful desensitization.
    Szyper-Kravitz M, Sheinberg P, Sidi Y, Schiffenbauer Y, Trubniykov E, Shoenfeld Y.
    Int Arch Allergy Immunol; 2005 Dec 03; 138(4):334-6. PubMed ID: 16224194
    [Abstract] [Full Text] [Related]

  • 20. A national survey on current use of mycophenolate mofetil for childhood-onset systemic lupus erythematosus in Japan.
    Hara R, Miyazawa H, Nishimura K, Momoi T, Nozawa T, Kikuchi M, Sakurai N, Kizawa T, Shimamura S, Yasuda S, Hiromura K, Sada KE, Kawaguchi Y, Tamura N, Takei S, Takasaki Y, Atsumi T, Mori M.
    Mod Rheumatol; 2015 Dec 03; 25(6):858-64. PubMed ID: 26215483
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.